• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Luminex法检测HLA特异性抗体时的自然干扰:特征与解决方法

Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution.

作者信息

Zachary Andrea A, Lucas Donna P, Detrick Barbara, Leffell Mary S

机构信息

Departments of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Hum Immunol. 2009 Jul;70(7):496-501. doi: 10.1016/j.humimm.2009.04.001. Epub 2009 Apr 11.

DOI:10.1016/j.humimm.2009.04.001
PMID:19364516
Abstract

Substances occurring naturally in the sera of patients can interfere with Luminex antibody assays, causing increased background and changes in antibody specificity. We present data on the effectiveness of hypotonic dialysis (HD) or dithiothreitol (DTT) treatment in eliminating this interference. HD significantly increased reaction strength of positive control beads and reduced reaction strength of negative control beads. HD also improved specificity identification, determination of donor-specific antibody (DSA) strength, and crossmatch predictability compared with values in untreated serum. DTT also increased the reaction strength of positive control beads, but in most cases, further increased reactivity of negative control beads. DTT improved crossmatch predictability but to a lesser extent than did HD and may differ with specificities defined in other assays. Because interference is frequently observed in sera from highly sensitized patients, it is important to recognize and eliminate interference in Luminex antibody assays for accurate and meaningful test interpretation.

摘要

患者血清中天然存在的物质会干扰Luminex抗体检测,导致背景增加和抗体特异性改变。我们展示了关于低渗透析(HD)或二硫苏糖醇(DTT)处理消除这种干扰有效性的数据。HD显著增加了阳性对照微珠的反应强度,并降低了阴性对照微珠的反应强度。与未处理血清中的值相比,HD还改善了特异性鉴定、供体特异性抗体(DSA)强度的测定以及交叉配型的可预测性。DTT也增加了阳性对照微珠的反应强度,但在大多数情况下,进一步增加了阴性对照微珠的反应性。DTT改善了交叉配型的可预测性,但程度低于HD,并且可能因其他检测中定义的特异性而异。由于在高度致敏患者的血清中经常观察到干扰,因此在Luminex抗体检测中识别和消除干扰对于准确和有意义的检测解读很重要。

相似文献

1
Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution.Luminex法检测HLA特异性抗体时的自然干扰:特征与解决方法
Hum Immunol. 2009 Jul;70(7):496-501. doi: 10.1016/j.humimm.2009.04.001. Epub 2009 Apr 11.
2
Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.肾移植中HLA抗体分析与交叉配型的重新评估
Clin Transpl. 2007:219-26.
3
Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera.采用二硫苏糖醇处理血清的改良基于 Luminex 的人类白细胞抗原特异性抗体筛查。
Hum Immunol. 2010 Jan;71(1):45-9. doi: 10.1016/j.humimm.2009.09.358.
4
Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.通过单抗原或多抗原微珠Luminex检测预测高度致敏患者的交叉配血结果。
Transplantation. 2006 Dec 15;82(11):1524-8. doi: 10.1097/01.tp.0000246311.43634.0a.
5
Identification of acceptable HLA mismatches in immunized patients using single-antigen-expressing cell lines.
Tissue Antigens. 2007 Apr;69(4):354-7. doi: 10.1111/j.1399-0039.2007.00821.x.
6
Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.Luminex检测抗HLA抗体的临床意义:加强对补体依赖细胞毒交叉配型试验(CDC-BXM)结果的解读及重要的移植后监测工具
Hum Immunol. 2009 Aug;70(8):595-9. doi: 10.1016/j.humimm.2009.06.010. Epub 2009 Jun 12.
7
The changing role of antibody testing in transplantation.抗体检测在移植中的角色转变。
Clin Transpl. 2005:259-71.
8
Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.抗人白细胞抗原特异性抗体浓度在进行计算性群体反应性抗体检测和虚拟交叉配型中的临床重要性
Transplantation. 2008 Apr 15;85(7):1046-50. doi: 10.1097/TP.0b013e318168fdb5.
9
Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.使用单抗原珠检测肾移植患者中免疫球蛋白G人类白细胞抗原特异性同种抗体时,免疫球蛋白M人类白细胞抗原特异性同种抗体的存在会影响检测结果。
Transplantation. 2009 Mar 27;87(6):813-20. doi: 10.1097/TP.0b013e318199c581.
10
Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation.固相检测抗 HLA 抗体的截断值和数据处理:对胸器官移植中不可接受抗原的列出的影响。
Hum Immunol. 2012 Jun;73(6):597-604. doi: 10.1016/j.humimm.2012.04.016. Epub 2012 Apr 23.

引用本文的文献

1
Early Donor-Specific HLA Antibodies Detected by Screening in the First Month Posttransplant and Kidney Graft Outcomes.移植后第一个月筛查发现的早期供体特异性 HLA 抗体与肾移植结局
Transpl Int. 2025 Aug 6;38:14424. doi: 10.3389/ti.2025.14424. eCollection 2025.
2
Development of the Crossmatch Test in Kidney Transplantation Up to the Virtual Level.肾脏移植交叉配型试验发展至虚拟水平
J Clin Med. 2025 Feb 15;14(4):1288. doi: 10.3390/jcm14041288.
3
Interrogating post-transplant donor HLA-specific antibody characteristics and effector functions using clinical bead assays.
使用临床微珠分析探究移植后供体HLA特异性抗体特征及效应功能。
Hum Immunol. 2024 Nov;85(6):111094. doi: 10.1016/j.humimm.2024.111094. Epub 2024 Oct 1.
4
Impact of COVID-19 pandemic on transplant laboratories: How to mitigate?2019冠状病毒病大流行对移植实验室的影响:如何缓解?
Heliyon. 2024 Feb 15;10(4):e26419. doi: 10.1016/j.heliyon.2024.e26419. eCollection 2024 Feb 29.
5
Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal.补体激活的供体特异性抗 HLA 抗体在实体器官移植中的应用:系统评价、荟萃分析和批判性评价。
Front Immunol. 2023 Oct 2;14:1265796. doi: 10.3389/fimmu.2023.1265796. eCollection 2023.
6
The natural history of donor-specific HLA antibodies after kidney transplantation.肾移植后供体特异性HLA抗体的自然病程。
Front Med (Lausanne). 2022 Sep 16;9:943502. doi: 10.3389/fmed.2022.943502. eCollection 2022.
7
European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group.欧洲器官移植学会工作组:《HLA 抗体阳性肾移植受者管理的欧洲指南》。
Transpl Int. 2022 Aug 10;35:10511. doi: 10.3389/ti.2022.10511. eCollection 2022.
8
Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots.基于 Luminex 的免疫分析法定量检测干血斑中脆性 X 蛋白的优化、验证及初步临床意义。
Sci Rep. 2022 Apr 4;12(1):5617. doi: 10.1038/s41598-022-09633-8.
9
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.移植中的致敏:风险评估(STAR)2019 工作组会议报告。
Am J Transplant. 2020 Oct;20(10):2652-2668. doi: 10.1111/ajt.15937. Epub 2020 May 27.
10
Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.在一个儿科移植队列中,对不同种族群体进行 Eplet 错配分析和同种异体移植结果:一项单中心分析。
Pediatr Nephrol. 2020 Jan;35(1):83-94. doi: 10.1007/s00467-019-04344-1. Epub 2019 Oct 10.